Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Tofacitinib> ?p ?o }
- Tofacitinib abstract "Tofacitinib (formerly tasocitinib, CP-690,550) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer. Tofacitinib is marketed as Xeljanz and Jakvinus.It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and other countries.It has demonstrated effectiveness in the treatment of psoriasis in Phase 3 studies. It is being studied for treatment of inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection.".
- Tofacitinib atcPrefix "L04".
- Tofacitinib atcSuffix "AA29".
- Tofacitinib bioavailability "74.0".
- Tofacitinib casNumber "477600-75-2".
- Tofacitinib chEBI "71200".
- Tofacitinib drugbank "DB08895".
- Tofacitinib fdaUniiCode "87LA6FU830".
- Tofacitinib iupacName "3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile".
- Tofacitinib pubchem "9926791".
- Tofacitinib thumbnail Tofacitinib2DACS.svg?width=300.
- Tofacitinib wikiPageID "30805678".
- Tofacitinib wikiPageLength "16584".
- Tofacitinib wikiPageOutDegree "85".
- Tofacitinib wikiPageRevisionID "707335577".
- Tofacitinib wikiPageWikiLink ACR_score_for_rheumatoid_arthritis.
- Tofacitinib wikiPageWikiLink Adverse_effect.
- Tofacitinib wikiPageWikiLink Blood_lipids.
- Tofacitinib wikiPageWikiLink Boxed_warning.
- Tofacitinib wikiPageWikiLink Brown_adipose_tissue.
- Tofacitinib wikiPageWikiLink CYP2C19.
- Tofacitinib wikiPageWikiLink CYP3A4.
- Tofacitinib wikiPageWikiLink Cancer.
- Tofacitinib wikiPageWikiLink Carcinogenesis.
- Tofacitinib wikiPageWikiLink Category:Non-receptor_tyrosine_kinase_inhibitors.
- Tofacitinib wikiPageWikiLink Category:Pyrrolopyrimidines.
- Tofacitinib wikiPageWikiLink Cell_nucleus.
- Tofacitinib wikiPageWikiLink Combination_therapy.
- Tofacitinib wikiPageWikiLink Common_cold.
- Tofacitinib wikiPageWikiLink Contraindication.
- Tofacitinib wikiPageWikiLink Controlled_clinical_trials.
- Tofacitinib wikiPageWikiLink Death.
- Tofacitinib wikiPageWikiLink Diarrhea.
- Tofacitinib wikiPageWikiLink Disease-modifying_antirheumatic_drug.
- Tofacitinib wikiPageWikiLink Drug_development.
- Tofacitinib wikiPageWikiLink Drug_discovery.
- Tofacitinib wikiPageWikiLink Efficacy.
- Tofacitinib wikiPageWikiLink Epstein–Barr_virus.
- Tofacitinib wikiPageWikiLink Etanercept.
- Tofacitinib wikiPageWikiLink Fertility.
- Tofacitinib wikiPageWikiLink Fluconazole.
- Tofacitinib wikiPageWikiLink Food_and_Drug_Administration.
- Tofacitinib wikiPageWikiLink Headache.
- Tofacitinib wikiPageWikiLink Hemoglobin.
- Tofacitinib wikiPageWikiLink High-density_lipoprotein.
- Tofacitinib wikiPageWikiLink Hospital.
- Tofacitinib wikiPageWikiLink Immunization.
- Tofacitinib wikiPageWikiLink Immunology.
- Tofacitinib wikiPageWikiLink Infection.
- Tofacitinib wikiPageWikiLink Inflammatory_bowel_disease.
- Tofacitinib wikiPageWikiLink Injury.
- Tofacitinib wikiPageWikiLink JAK-STAT_signaling_pathway.
- Tofacitinib wikiPageWikiLink Janus_kinase.
- Tofacitinib wikiPageWikiLink Janus_kinase_1.
- Tofacitinib wikiPageWikiLink Janus_kinase_inhibitor.
- Tofacitinib wikiPageWikiLink John_OShea_(biologist).
- Tofacitinib wikiPageWikiLink Ketoconazole.
- Tofacitinib wikiPageWikiLink Kidney_transplantation.
- Tofacitinib wikiPageWikiLink Lipid.
- Tofacitinib wikiPageWikiLink Liver_function_tests.
- Tofacitinib wikiPageWikiLink Low-density_lipoprotein.
- Tofacitinib wikiPageWikiLink Lymphocyte.
- Tofacitinib wikiPageWikiLink Lymphoma.
- Tofacitinib wikiPageWikiLink Lymphoproliferative_disorders.
- Tofacitinib wikiPageWikiLink Methotrexate.
- Tofacitinib wikiPageWikiLink Mutagenesis.
- Tofacitinib wikiPageWikiLink National_Institute_of_Arthritis_and_Musculoskeletal_and_Skin_Diseases.
- Tofacitinib wikiPageWikiLink National_Institutes_of_Health.
- Tofacitinib wikiPageWikiLink Neutropenia.
- Tofacitinib wikiPageWikiLink Neutrophil_granulocyte.
- Tofacitinib wikiPageWikiLink Obesity.
- Tofacitinib wikiPageWikiLink Opportunistic_infection.
- Tofacitinib wikiPageWikiLink Organ_transplantation.
- Tofacitinib wikiPageWikiLink Pfizer.
- Tofacitinib wikiPageWikiLink Pharmaceutical_drug.
- Tofacitinib wikiPageWikiLink Phases_of_clinical_research.
- Tofacitinib wikiPageWikiLink Placebo.
- Tofacitinib wikiPageWikiLink Pre-clinical_development.
- Tofacitinib wikiPageWikiLink Psoriasis.
- Tofacitinib wikiPageWikiLink Psoriasis_Area_and_Severity_Index.
- Tofacitinib wikiPageWikiLink Rheumatoid_arthritis.
- Tofacitinib wikiPageWikiLink Rheumatology.
- Tofacitinib wikiPageWikiLink STAT1.
- Tofacitinib wikiPageWikiLink Transcription_(genetics).
- Tofacitinib wikiPageWikiLink Tuberculosis.
- Tofacitinib wikiPageWikiLink Ulcerative_colitis.
- Tofacitinib wikiPageWikiLink United_States.
- Tofacitinib wikiPageWikiLink Upper_respiratory_tract_infection.
- Tofacitinib wikiPageWikiLink Vaccine.
- Tofacitinib wikiPageWikiLink Vitiligo.
- Tofacitinib wikiPageWikiLink White_adipose_tissue.
- Tofacitinib wikiPageWikiLinkText "Tofacitinib".
- Tofacitinib wikiPageWikiLinkText "tofacitinib".
- Tofacitinib atcPrefix "L04".
- Tofacitinib atcSuffix "AA29".
- Tofacitinib bioavailability "74.0".
- Tofacitinib c "16".
- Tofacitinib casNumber "477600".
- Tofacitinib chebi "71200".
- Tofacitinib chembl "221959".